Imipramine Pamoate (Lupin Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Imipramine Pamoate drug offered from Lupin Pharmaceuticals, Inc.. This Tricyclic Antidepressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Lupin Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Imipramine Pamoate
SUBSTANCE NAME: IMIPRAMINE PAMOATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Tricyclic Antidepressant [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-04-16
END MARKETING DATE: 0000-00-00


Imipramine Pamoate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionImipramine Pamoate from Lupin Pharmaceuticals, Inc.
LABELER NAME: Lupin Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 75(mg/1)
START MARKETING DATE: 2010-04-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68180-314_f15dcc43-e01d-4c06-8eb8-b6993de8794c
PRODUCT NDC: 68180-314
APPLICATION NUMBER: ANDA090444

Other IMIPRAMINE PAMOATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalImipramine Pamoate
LUPIN LIMITEDImipramine Pamoate
Lupin Pharmaceuticals, Inc.Imipramine Pamoate
STAT RX USA LLCIMIPRAMINE PAMOATE
West-Ward Pharmaceuticals Corp.Imipramine Pamoate